Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes

Abstract Cardiovascular disease (CVD) is the leading cause of mortality and morbidity in patients with type 2 diabetes (T2D). Historical concerns about cardiovascular (CV) risks associated with certain glucose-lowering medications gave rise to the introduction of cardiovascular outcomes trials (CVOT...

Full description

Bibliographic Details

Published in:	Cardiovascular Diabetology
Main Authors:	Melanie J. Davies, Heinz Drexel, François R. Jornayvaz, Zoltan Pataky, Petar M. Seferović, Christoph Wanner
Format:	Article
Language:	English
Published:	BMC 2022-08-01
Subjects:	Cardiovascular disease Cardiovascular outcomes trials Chronic kidney disease CVOTs Cardiovascular safety Heart failure
Online Access:	https://doi.org/10.1186/s12933-022-01575-9